Northwest Biotherapeutics NWBO
OTC NWBO
$0.17 +0.01 (+6.25%)
At close: Oct 21, 2026 · 4:00 PM EDT

Northwest Biotherapeutics (NWBO) Acquisitions (2020)

Updated

Northwest Biotherapeutics (NWBO) reported Acquisitions of -$28,000 for Q4 2020.

Analysis

Northwest Biotherapeutics (NWBO) Acquisitions (2020) Analysis & Trends

For FY2020, Northwest Biotherapeutics posted Acquisitions of $1.53 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,170.46 Bn 1,139.04 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 648.38 Bn 568.24 Bn 17.30 Bn -17.15 Bn
3 AbbVie 504.43 Bn 477.54 Bn 12.70 Bn -
4 Merck 367.73 Bn 322.11 Bn 12.21 Bn -
5 Novartis Ag 303.35 Bn 267.34 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 268.20 Bn 241.88 Bn 12.86 Bn -
7 Amgen 242.55 Bn 197.95 Bn 7.24 Bn -
8 Gilead Sciences 194.80 Bn 169.00 Bn 6.22 Bn 11.21 Bn
9 Pfizer 173.31 Bn 119.95 Bn 10.94 Bn -
10 Northwest Biotherapeutics 249.65 Mn 239.67 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -28,000.00
API Access

Northwest Biotherapeutics Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=NWBO&period=max&api_key=YOUR_API_KEY